immuno-conjugate

Interviews and expert commentary tagged “immuno-conjugate” — the latest oncology research and clinical practice from the Audio Journal of Oncology.

PSA-membrane antibody conjugate shows promise for treating metastatic castration-resistant, taxane-refractory prostate cancer
Audio Journal of Oncology

PSA-membrane antibody conjugate shows promise for treating metastatic castration-resistant, taxane-refractory prostate cancer

SAN FRANCISCO—A “guided missile” approach to treating metastatic, castration-resistant, taxane-refractory prostate cancer demonstrated success at the 2014 ASCO Genitourinary Cancers Sympos

6 February 2014
0:00
The TH3RESA study: TDM-1 doubles progression free survival in HER-2 positive refractory metastatic breast cancer.
Audio Journal of Oncology

The TH3RESA study: TDM-1 doubles progression free survival in HER-2 positive refractory metastatic breast cancer.

AMSTERDAM—Women with HER-2 positive metastatic breast cancer had significantly improved time to progression with fewer side effects after treatment with the antibody-drug conjugate T-DM1 compared to c

19 November 2013
0:00